In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight Infants

Trial ID or NCT#

NCT01203501

Status

not recruiting iconNOT RECRUITING

Purpose

This study examined the effect of magnesium sulfate (MgSO4) exposure on adverse outcome in extremely low birth weight (ELBW) infants. For infants included in the NICHD Neonatal Research Network Generic Database whose mothers were given prenatal MgSO4, data were prospectively collected on maternal/infant conditions and magnesium exposure (including indications, timing and duration of exposure).

Official Title

In Utero Magnesium Sulfate Exposure: Effects on Extremely-Low-Birth-Weight (ELBW) Infants

Eligibility Criteria

Ages Eligible for Study: Younger than 14 Days
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. * Infants born in NRN Centers with a birth weight of 401-1,500g
Exclusion Criteria:
  1. * None
View All Criteria
Show Less

Investigator(s)

David K. Stevenson, M.D.

View on ClinicalTrials.gov